Prednisolon GALEN

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Prednisolon GALEN

Property Description
Active ingredient Prednisolone Acetate (an ester derivative)
Form Injection suspension, Ophthalmic solution/suspension, Tablets
Pharmacological class Synthetic Glucocorticoid (Corticosteroid)
General purpose Suppression of inflammation and immune activity
Origin Synthetic (chemically synthesized analog)

What Type of Medicine is Prednisolon GALEN?

Prednisolon GALEN is a brand-specific medicinal preparation classified as a Synthetic Glucocorticoid, which is a subset of the larger Corticosteroid family of drugs. This classification describes its role in regulating the body's inflammatory and immune pathways. Its active component, Prednisolone Acetate, is a chemical derivative engineered to amplify the actions of cortisol, the anti-inflammatory hormone naturally produced by the adrenal cortex. This drug is entirely synthetic in origin, allowing for precise control over its potency and stability. Prednisolon GALEN is primarily available as a prescription-only (Rx) medicine, reflecting the potency and controlled nature of this therapeutic class.

Composition, Preparation, and General Purpose

The foundation of Prednisolon GALEN is its single-ingredient active compound, Prednisolone Acetate, an esterified form of Prednisolone. The formulation is provided as a sterile suspension for parenteral (injection) administration, a feature often chosen when rapid, localized, and sustained effects are required. Corticosteroids are broadly employed due to their effective immunosuppressive actions. This means that this drug class, including Prednisolone, is recognized for its ability to help limit the reactions of the immune system that can damage healthy tissues. The overall general purpose of Prednisolone Acetate is the relief of severe inflammation and the stabilization of tissues affected by excessive or destructive immune activity across various conditions where immune modulation is beneficial.

Regulatory References

  1. Steroids - MedlinePlus
Advertisements

What side effects are possible with Prednisolon GALEN?

Possible Side Effects and Safety Information

The safety profile of Prednisolon GALEN, a systemic glucocorticoid, is based on extensive regulatory documentation which categorizes possible adverse reactions by frequency and physiological system. This information describes the characteristics of the medicine's risk profile without providing clinical advice.

Documented Adverse Reactions

Adverse effects are broadly classified across several System-Organ Classes (SOCs), reflecting the drug's widespread action. Key areas include Endocrine and Metabolic Disorders (e.g., altered glucose tolerance, HPA axis suppression), Musculoskeletal (e.g., loss of muscle mass, osteoporosis), Gastrointestinal (e.g., peptic ulceration), and Nervous System/Psychiatric (e.g., mood disturbances, insomnia).

Reactions classified as Common in regulatory documents often include fluid retention, weight gain, hypertension, and behavioral changes.

Serious Safety Considerations

The official labeling documents several Serious Adverse Reactions. These include Acute Adrenal Insufficiency, particularly upon abrupt discontinuation, and the potential for Gastrointestinal Perforation or severe Psychotic Manifestations.

Exposure Patterns and Restrictions

The risk of significant adverse effects is frequently tied to the duration of exposure. Effects such as osteoporosis, cataract formation, and growth suppression in pediatric patients are primarily associated with long-term exposure.

Specific safety-related restrictions are documented. The medicine is contraindicated in patients with systemic fungal infections unless concurrent anti-infective therapy is employed. Furthermore, official documentation states that live or live attenuated vaccines should not be administered to patients receiving immunosuppressive doses.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that a single, large acute overdose of prednisolone is generally not expected to produce life-threatening symptoms. The primary risk for serious toxicity is associated with the prolonged use of excessive doses.

Prolonged overdose may lead to symptoms consistent with Cushing's syndrome and significant systemic effects, including adrenal insufficiency following abrupt cessation.

Overdose Manifestations Serious Outcomes
Symptoms of fluid/electrolyte imbalance (e.g., hypertension) Seizures or Convulsions
Gastrointestinal effects (e.g., vomiting) Acute Adrenal Insufficiency
Sleep disturbance/restlessness Severe Electrolyte Disturbances

Emergency Actions and Seeking Urgent Help

There is no specific pharmacological antidote for prednisolone overdose; management is strictly symptomatic and supportive, focusing on correcting electrolyte imbalances (sodium and potassium) and maintaining vital functions.

Immediate medical attention is required if an individual exhibits severe manifestations, including:

  • A collapse or inability to be awakened
  • A seizure or convulsion
  • Signs of gastrointestinal bleeding, such as bloody or black, tarry stools

Contact emergency services or a poison control center immediately for advice in any suspected overdose situation. Overdose effects may be heightened in individuals with pre-existing kidney or liver impairment.

Advertisements

Therapeutic Uses of Prednisolon GALEN

Main Uses and Therapeutic Scope

Prednisolon GALEN is a glucocorticoid medication used to treat a wide range of conditions characterized by inflammation or an overactive immune response. As a synthetic derivative of the natural hormone cortisol, it acts as a systemic treatment when local applications are insufficient or inappropriate.

Inflammatory and Autoimmune Conditions

The primary benefit of this medication is its ability to reduce inflammation and suppress the immune system. It is utilized across several medical fields:

  • Rheumatology: Treatment of active phases of systemic autoimmune diseases, such as systemic lupus erythematosus, and inflammatory joint conditions like rheumatoid arthritis or juvenile idiopathic arthritis.
  • Pulmonology: Management of severe inflammatory airway diseases, including acute exacerbations of bronchial asthma or chronic obstructive pulmonary disease (COPD).
  • Dermatology: Treatment of severe, acute skin diseases that cannot be adequately managed with topical steroids, such as extensive eczema, pemphigus vulgaris, or severe inflammatory rashes.
  • Gastroenterology: Management of acute flares in chronic inflammatory bowel diseases, such as Crohn's disease or ulcerative colitis.

Specialized Applications

Beyond general inflammatory conditions, the medication is applied in specific therapeutic contexts:

  • Allergic Reactions: Treatment of severe allergic symptoms that do not respond to other therapies.
  • Hematology and Oncology: Support in the treatment of certain blood disorders or as part of specific protocols for malignant diseases, such as certain types of leukemia or lymphoma.
  • Hormone Replacement: In cases of adrenal insufficiency (where the body does not produce enough natural cortisol), it may be used as part of a replacement therapy regimen, though this is often combined with other mineralocorticoids.
  • Ophthalmology: Treatment of systemic inflammatory processes affecting the eyes, such as uveitis or optic neuritis.

Mechanisms of Action

Prednisolon GALEN works by mimicking the effects of hormones produced by the adrenal cortex. By binding to specific receptors within cells, it modifies the body's immune response and inhibits the production of substances that trigger inflammation. This helps to reduce swelling, redness, pain, and tissue damage associated with chronic or acute inflammatory processes.

Regulatory References

  1. Prednisolone MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Prednisolon GALEN is restricted to specific populations as detailed in official government regulatory documents. Eligibility is defined by absolute prohibitions, conditional use requirements, and limitations concerning age and coexisting health conditions.

Category Official Regulatory Status
Absolute Contraindications Systemic fungal infections and known hypersensitivity to the drug or its components.
Populations for Use with Caution Patients with diabetes mellitus, severe osteoporosis, hypertension, renal insufficiency, and certain gastrointestinal disorders (e.g., active or latent peptic ulcers).
Age-Group Limitations Pediatric use requires close and regular monitoring of growth and development due to the labeled risk of growth suppression. Older Adults (Geriatric) require cautious use due to increased susceptibility to age-related issues.
Pregnancy and Lactation Status Conditional Use: Use during pregnancy is allowed only if the potential benefit outweighs the potential fetal risk. If used while breastfeeding, the lowest effective dose is recommended, with monitoring advised for the infant at higher maternal doses.

Official prescribing information mandates that non-immune patients should avoid exposure to diseases like chickenpox or measles, and patients on immunosuppressive doses must not receive live or live attenuated vaccines.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Prednisolon GALEN is defined by specific patterns documented in official regulatory labeling. These interactions primarily involve changes to drug exposure and the enhancement of certain physiological risks.

Co-administration with strong CYP3A4 Inducers (e.g., Rifampicin, Phenytoin) is documented to reduce Prednisolone plasma concentration through accelerated metabolism. Conversely, strong CYP3A4 Inhibitors (e.g., Ketoconazole, certain Macrolide Antibiotics) are documented to increase systemic exposure due to decreased clearance. Oral Contraceptives are also officially noted to reduce Prednisolone clearance, resulting in elevated plasma levels.

The regulatory label strictly restricts co-administration with Live or Live-Attenuated Vaccines during high-dose therapy due to the risk associated with immunosuppression. Pharmacodynamic interactions include an officially documented increased risk of gastrointestinal adverse effects when combined with NSAIDs. Furthermore, combination with potassium-losing diuretics is documented to enhance the risk of hypokalemia. Certain substances, such as antacids and bile acid sequestrants, are documented to interfere with absorption and require a mandatory separation of administration by an officially specified time interval to ensure adequate uptake.

Advertisements

Mechanism of Action

Receptor-Mediated Gene Reprogramming

Prednisolone, the active component, operates as an agonist for the ubiquitous intracellular Glucocorticoid Receptor ( GR). After binding, this activated complex translocates to the cell nucleus and directly reprograms genetic expression, a process known as transrepression. This molecular action fundamentally switches off the master genetic instructions ( NF-kappa B, AP-1) for creating inflammatory mediators like cytokines and chemokines. The resulting physiological change is a reduction in the signaling activity of cellular mechanisms mediating the inflammatory response.

Cascade Inhibition and Immune Cell Modulation

This genomic reprogramming leads to the synthesis of inhibitory proteins, such as Lipocortin-1, which in turn block the enzyme Phospholipase A2 ( PLA2). By preventing PLA2 activity, the drug starves the Arachidonic Acid cascade of its precursors, leading to reduced production of Prostaglandins and Leukotrienes that serve as local mediators of inflammation. Furthermore, the drug alters the movement and survival of white blood cells, reducing the number of available immune cells required to sustain an immune response. This systemic modulation alters immune cell distribution, affecting the physiological response at the tissue level.

Advertisements

Dosage and Administration Information

How Prednisolon GALEN is Used

The administration of prednisolone is determined by its dosage form, which includes oral tablets or solutions for systemic therapy, an ophthalmic suspension for topical application, and an injection suspension for parenteral use. The medicine is utilized across these different routes according to the specific formulation provided.

Administration Patterns

Use Principle Instruction
Systemic Dosing The initial adult daily oral dose typically ranges from 5 mg to 60 mg of prednisolone equivalent, administered either once daily or in divided doses.
Systemic Timing Oral forms are generally taken with food to help mitigate gastrointestinal irritation.
Topical Ocular Dosing The standard regimen involves instilling one to two drops into the affected eye two to four times daily. For severe, acute inflammation, the frequency may be increased to as often as every hour.
Ocular Preparation The ophthalmic suspension is shaken well immediately before each application to ensure the proper dispersal of the active ingredient.
Therapy Completion If the medicine is used at a high dose or for a prolonged period, gradual withdrawal (tapering) is utilized to complete therapy. Use of the ocular form for 10 days or longer involves specific supervision.
Pediatric Use Systemic dosage for children is determined by the disease severity and response. Ocular use is generally not recommended for children under 12 years of age.

The usage protocol is structured so that the method of administration aligns with the requirements for the specific form. The dosage and frequency are defined within these ranges, and long-term systemic use is concluded with a gradual tapering pattern.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prednisolon GALEN

Prednisolon GALEN is the brand name for a medicine containing Prednisolone Acetate, and its research evidence base is characterized by two distinct areas of study: its use as an eye drop (ophthalmic suspension) for local inflammation and its systemic use (oral or injection) for acute body-wide inflammatory or allergic episodes. According to regulatory reviews, the evidence landscape primarily consists of randomized controlled trials (RCTs) and systematic reviews, which contributes to the understanding of patterns observed in the studies.


Evidence for Use in Acute Ocular Inflammation

The research exploring the ophthalmic use of Prednisolon GALEN has focused heavily on studying the measurement of intense inflammation in the front part of the eye, particularly following eye surgery. These studies are often short-term Randomized Controlled Trials (RCTs) and Systematic Reviews that pool findings from multiple trials.

Researchers monitored outcomes related to physical discomfort and the body’s inflammatory response. For example, studies used specific measures like anterior chamber cell and flare scores to track how the observable signs of inflammation evolved over the study period. The studies included both adults and some groups of pediatric patients who had undergone procedures like cataract or glaucoma surgery.

The pooled findings from this body of evidence describe patterns observed in the studies, where the measured inflammatory scores were typically observed as lower in the treated groups during the initial acute phase of the study when compared to controls. This evidence contributes to understanding symptom patterns in the immediate post-surgical setting.


Evidence for Use in Acute Systemic Inflammatory and Allergic Flares

Research exploring the systemic application of corticosteroids is relevant in trials assessing short-term or episodic symptom patterns, such as those associated with flare-ups of chronic conditions. The evidence here comes from RCTs and larger Observational Studies.

In these contexts, research examined outcomes related to systemic or functional imbalance, such as breathing difficulty or physical discomfort in conditions like asthma exacerbations. Studies reported how symptoms evolved in the observed populations, indicating that patterns of symptomatic change were observed during the study period when compared to controls in some acute respiratory settings. However, when observational settings evaluated daily-life functioning and relapse rates for acute allergic reactions, the findings were mixed, and data show patterns related to inconsistent or limited findings regarding the prevention of recurrent symptoms.

Key Studies & References

  1. MedlinePlus Drug Information: Prednisolone (Systemic and Ophthalmic uses)
  2. NIH PubChem Classification: Corticosteroid Class Definition
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Prednisolon GALEN (FAQ)


Q: Does Prednisolon GALEN cause weight gain, and is it permanent?

A: Regulatory documents indicate that weight gain and fluid retention are common adverse reactions associated with Prednisolone use. These changes are often related to the dosage and how long the medication is taken. Official information suggests that these effects typically resolve after the treatment is stopped, though this process may take time.


Q: Will I experience withdrawal symptoms if I stop taking Prednisolon GALEN too quickly?

A: Abrupt discontinuation of the drug, especially after prolonged use, is a known risk factor for Acute Adrenal Insufficiency. This occurs because the body's natural production of the hormone cortisol has been suppressed. For this reason, official guidelines advise a gradual reduction in dosage, known as tapering, which is intended to allow the body's hormone production to recover.


Q: Is Prednisolon GALEN safe to take while breastfeeding?

A: Official information confirms that Prednisolone is passed into breast milk, generally in small amounts. Official guidelines generally advise that if the medication is necessary, the lowest effective dose should be considered, and the infant should be monitored for potential effects.


Q: Is there a link between long-term use of Prednisolon GALEN and bone density?

A: Official prescribing information documents that prolonged exposure to this class of medication is associated with risks to the musculoskeletal system. This includes decreased bone density and an increased risk of developing osteoporosis.


Q: What over-the-counter pain relievers interact with Prednisolon GALEN?

A: Official documents note an increased risk of gastrointestinal side effects, such as ulcers and internal bleeding, when this medication is used in combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class which includes many common over-the-counter pain relievers.


Q: Does Prednisolon GALEN affect blood pressure?

A: Yes, official safety information lists elevated blood pressure, or hypertension, as a commonly reported adverse reaction associated with the use of Prednisolone.


Q: Can this medication cause changes to my skin, like thinning or bruising?

A: Regulatory documents list dermatologic (skin) adverse effects, including skin atrophy (thinning) and ecchymosis or petechiae (bruising). These changes are typically associated with prolonged use of corticosteroids.


Q: Why are people often told to monitor their sugar levels while on Prednisolone?

A: Prednisolone can cause or worsen pre-existing diabetes and may lead to altered glucose tolerance or hyperglycemia (high blood sugar). Therefore, monitoring blood sugar levels is important to manage these potential metabolic changes.


Q: Is it normal to feel more energetic or restless when taking Prednisolon GALEN?

A: Official prescribing information reports that psychiatric disturbances are possible with this drug. These effects may manifest as changes like euphoria, restlessness, or behavioral changes.


Q: What are the signs that I might be having a serious side effect from Prednisolon GALEN?

A: Regulatory documents list specific symptoms associated with serious risks, such as severe, unusual abdominal pain or significant, rapid changes in behavior. Any new or concerning symptoms should be discussed with a healthcare provider.


Q: Will Prednisolon GALEN affect my sleep schedule?

A: Yes, regulatory documents list insomnia (difficulty falling or staying asleep) as a common adverse effect associated with this medication.


Q: Can Prednisolon GALEN be used for allergic reactions?

A: Prednisolone is officially indicated for the management of certain severe or incapacitating allergic conditions that have been unresponsive to conventional treatments. This includes conditions like severe asthma or drug hypersensitivity reactions.


Q: Does Prednisolon GALEN make you feel hungry all the time?

A: Official information indicates that the drug can increase appetite, which is a factor contributing to the documented side effect of weight gain.


Q: Is it safe to take Prednisolon GALEN if I have diabetes?

A: Prednisolone should be used with caution in patients with diabetes mellitus. This is because the drug can raise blood sugar levels, often requiring close monitoring and possible adjustment of existing diabetes treatment.


Q: Can Prednisolon GALEN affect your mood or cause mood swings?

A: Yes, the official product information lists psychic derangements as documented adverse effects. These can include emotional instability, mood swings, euphoria, or other mood disturbances.


Q: Is Prednisolon GALEN commonly used for autoimmune disorders?

A: The drug is classified as an immunosuppressant, and it is indicated for use in managing specific autoimmune diseases. These include acute exacerbations of conditions like multiple sclerosis or ulcerative colitis.


Q: What kind of infections are a concern when taking Prednisolon GALEN?

A: Due to its effect on the immune system, the medication increases susceptibility to infections, including viral, bacterial, and fungal infections. Official warnings note the risk of serious outcomes from exposure to specific diseases, such as chickenpox or measles, in patients who are not immune.


Q: Why is it important to carry a steroid card when taking this medicine?

A: A steroid card is often recommended for patients on high-dose or long-term therapy. This card is used to alert emergency medical personnel that the patient may need a supplemental dose of corticosteroid during severe physical stress to prevent Acute Adrenal Insufficiency.


Q: What are common gastrointestinal issues reported with Prednisolon GALEN?

A: Official labeling documents gastrointestinal side effects including peptic ulceration, nausea, and vomiting. The drug is typically instructed to be taken with food to help reduce irritation to the stomach.


Q: Why is it recommended to take Prednisolon GALEN in the morning?

A: The medication is often prescribed for morning administration to align with the body’s natural circadian rhythm of cortisol production. This timing is intended to help minimize the risk of suppressing the body's own hormone production and can help reduce insomnia.


Q: How does Prednisolon GALEN help with asthma?

A: The medication is indicated for the management of severe or incapacitating allergic and respiratory conditions, including asthma. It works by using its anti-inflammatory and immunosuppressant properties to suppress the body’s excessive immune response that causes inflammation in the airways.


Q: Is it normal for my face to look puffy (moon face) after a few weeks of use?

A: A Cushingoid appearance, commonly called 'moon face,' is a documented, visible side effect. It is a sign of fluid retention and changes in fat distribution associated with the use of corticosteroids, especially with longer-term therapy.


Q: What should I do if I accidentally skip a dose of Prednisolon GALEN?

A: Official patient information often suggests that if a dose is missed, it should be taken as soon as it is remembered on the same day, unless it is nearly time for the next scheduled dose. This approach helps to avoid taking too much medicine at once.


Q: Can Prednisolon GALEN weaken the immune system?

A: Official information states that Prednisolone is classified as an immunosuppressant. High or prolonged doses are documented to suppress the immune system, which makes patients more susceptible to infections.


Q: What are the main benefits of taking Prednisolon GALEN for chronic conditions?

A: Its intended purpose is to reduce severe inflammation and manage symptoms that may be unresponsive to other therapies. It helps to regulate immune activity and provide symptomatic relief in chronic conditions.


Q: Does Prednisolon GALEN affect cholesterol levels?

A: Regulatory documents list changes in lipid profiles (fats in the blood), which includes cholesterol and triglycerides, as a possible metabolic adverse effect.


Q: What common antibiotics should not be taken with Prednisolon GALEN?

A: The drug’s concentration in the body can be increased by co-administration with strong inhibitors of the CYP3A4 enzyme, such as certain Macrolide antibiotics (e.g., erythromycin). This interaction is due to decreased clearance of Prednisolone.


Q: Is Prednisolon GALEN a painkiller?

A: Prednisolone is classified as a Glucocorticoid, which is primarily an anti-inflammatory and immunosuppressant medication. While it can relieve pain by reducing inflammation and swelling, it is not classified as a direct analgesic (painkiller).


Q: Does this medicine affect fertility?

A: Official documentation notes that in males, high-dose, long-term use has been associated with disturbances in sperm production, though this may resolve after the drug is stopped. Definitive statements regarding the overall impact on female fertility are not available.


Q: Can Prednisolon GALEN cause stomach ulcers?

A: Yes, the official safety information lists peptic ulceration as a documented gastrointestinal adverse effect associated with the use of this medication.


Q: What is the shelf life of Prednisolon GALEN tablets?

A: The official shelf life for the tablet formulation is typically stated in regulatory documents, such as the Summary of Product Characteristics (SmPC), as two years when stored under the specified conditions.


Q: Does Prednisolon GALEN affect how my body heals from injuries?

A: Yes, official warnings note that corticosteroids may slow the rate of wound healing. This is a potential risk that is specifically noted regarding use in patients with recent surgery or existing ulcers.

Advertisements

How should Prednisolon GALEN be stored and disposed of?

Storage and Disposal Requirements for Prednisolon GALEN

Prednisolon GALEN must be stored according to regulatory requirements to maintain its chemical stability and potency.


Official Storage Conditions

Requirement Description
Temperature Store at controlled room temperature, typically not above 25°C.
Protection Keep the medicine protected from light and excessive moisture.
Container Must be kept in the original container, tightly closed, to maintain stability.

Handling and Disposal Rules

  • Child Safety: It is mandatory to keep the product out of the sight and reach of children at all times.
  • Handling: Do not freeze liquid formulations of this medicine.
  • Disposal: Unused or expired Prednisolon GALEN must not be disposed of via household trash or wastewater (e.g., sink or toilet). Return the product to a pharmacist or official drug take-back program for proper disposal, adhering to environmental protection rules.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednisolon GALEN found in:

A-Z Index: